The Food and Drug Administration’s approval in 2023 of lecanemab — a novel Alzheimer’s therapy shown in clinical trials to…
Read More »Tolerated
In October 2020, Francis Collins, then the director of the National Institutes of Health, sent an email that maligned a…
Read More »